AB0528 CORRELATION BETWEEN ALBUMIN TO GLOBULIN RATIO AND DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Author:

Liu M.,Huang Y.,Huang Z.,Huang Z.,Huang Q.,Li T.

Abstract

BackgroundNeutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have been reported as useful inflammatory biomarkers associated with the disease activity of systemic lupus erythematosus (SLE). Recently, the albumin to globulin ratio (AGR) has emerged as a potential indicator to predict the prognosis of some cancers. However, whether AGR can predict the disease activity of SLE has been rarely investigated.ObjectivesThis study was to explore the relation between AGR and SLE Disease Activity Index 2000 (SLEDAI-2K) in patients with SLE.MethodsThis retrospective study enrolled 101 SLE patients and 75 age- and gender-matched healthy individuals. According to the SLEDAI-2K score, SLE patients were classified into Group 1 with a score of 9 or lower (patients with mild disease activity, N = 60) and Group 2 with a score > 9 (patients with moderate to severe disease activity, N = 41). Albumin, globulin, NLR, PLR, monocyte to lymphocyte ratio (MLR), AGR, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), complement 3 (C3), complement 4 (C4), SLEDAI-2K and other clinical data were collected. Receiver operation characteristic (ROC) curves were conducted to discriminate SLE patients from healthy controls and SLE patients with different disease activity. Correlations between the inflammatory markers and SLEDAI-2K were checked. The prognostic value of AGR in the SLE disease activity was tested by logistical regression analyses.ResultsAlbumin and AGR in SLE patients were lower compared to those of the healthy controls (P < 0.05), while NLR, PLR, MLR, globulin and CRP were higher (P < 0.05). Patients in Group 2 had lower levels of albumin, AGR, C3 and C4 than those in Group 1 (P < 0.05), NLR and PLR were higher (P < 0.05), while MLR (P = 0.198), globulin (P = 0.704), CRP (P = 0.224) and ESR (P = 0.135) displayed no significant differences. The ROC curves for differentiating SLE patients from healthy individuals showed that the area under curve (AUC) of AGR (0.812, 95%CI: 0.750 - 0.874) and albumin (0.840, 95%CI: 0.782 - 0.898) were higher than NLR (0.786, 95%CI: 0.719 - 0.853), PLR (0.708, 95%CI: 0.629 - 0.786), MLR (0.776, 95%CI: 0.708 - 0.845) and globulin (0.630, 95%CI: 0.548 - 0.713). Similarly, the ROC curves for predicting the disease activity of SLE patients displayed that the AUC of AGR (0.779, 95%CI: 0.689 - 0.870) and albumin (0.827, 95%CI: 0.746 - 0.909) were also higher than NLR (0.644, 95%CI: 0.534 - 0.753), PLR (0.672, 95%CI: 0.565 - 0.780), MLR (0.583, 95%CI: 0.466 - 0.701), globulin (0.521, 95%CI: 0.403 - 0.639), CRP (0.567, 95%CI: 0.452 - 0.683), ESR (0.589, 95%CI: 0.475 - 0.703), C3 (0.709, 95%CI: 0.603 - 0.815) and C4 (0.655, 95%CI: 0.542 - 0.768). AGR was negatively correlated with SLEDAI-2K (r = -0.543, P < 0.001) in SLE patients. Logistical regression analyses showed that AGR (OR = 13.047, 95%CI: 3.407 - 49.966, P < 0.001) was an inverse predictor for SLE disease activity, yielding a highest hazard than other inflammatory parameters.ConclusionAGR was significantly decreased in SLE patients compared with healthy subjects and negatively associated with the disease activity of SLE. AGR might be a potential indicator for evaluating inflammation in patients with SLE.References[1]Zhang Y, Wang L, Lin S, et al. Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis[J]. Cancer Manag Res, 2018,10:4695-4708.Disclosure of InterestsNone declared

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3